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Matrix metalloproteaseInﬂuenza A virus (IAV) is one of the most common infectious pathogens in humans. Since the IVA genome
does not have the processing protease for the viral hemagglutinin (HA) envelope glycoprotein precursors,
entry of this virus into cells and infectious organ tropism of IAV are primarily determined by host cellular
trypsin-type HA processing proteases. Several secretion-type HA processing proteases for seasonal IAV in the
airway, and ubiquitously expressed furin and pro-protein convertases for highly pathogenic avian inﬂuenza
(HPAI) virus, have been reported. Recently, other HA-processing proteases for seasonal IAV and HPAI have
been identiﬁed in the membrane fraction. These proteases proteolytically activate viral multiplication at the
time of viral entry and budding. In addition to the role of host cellular proteases in IAV pathogenicity, IAV
infection results in marked upregulation of cellular trypsins andmatrix metalloproteinase-9 in various organs
and cells, particularly endothelial cells, through induced pro-inﬂammatory cytokines. These host cellular
factors interact with each other as the inﬂuenza virus–cytokine–protease cycle, which is the major
mechanism that induces vascular hyperpermeability and multiorgan failure in severe inﬂuenza. This mini-
review discusses the roles of cellular proteases in the pathogenesis of IAV and highlights the molecular
mechanisms of upregulation of trypsins as effective targets for the control of IAV infection. This article is part
of a Special Issue entitled: Proteolysis 50 years after the discovery of lysosome.Proteolysis 50 years after the
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Inﬂuenza A virus (IAV), a single-stranded negative-sense RNA virus,
is the most common infective pathogen in human, causing signiﬁcant
morbidity andmortality in infants and elderly [1,2]. In theprocess of IAV
entry into cells, proteolytic processing of the viral envelope fusion
glycoprotein, hemagglutinin (HA), by host cellular trypsin type pro-
teases is a pre-requisite for membrane fusion activity [3–5]. Further-
more, IAV infection signiﬁcantly upregulates cellular trypsins and pro-
matrix metalloproteinase-9 (MMP-9) in various organs and vascular
endothelial cells [4,6–8]. Upregulated trypsins potentiate further viral
multiplication by conversion of HA0 into HA1 and HA2 and also cause
damage through proteinase-activated receptor-2 (PAR-2) in various
tissues [7]. Therefore, in inﬂuenza virus-induced pneumonia, acute
myocarditis and myocardial infarction [9,10], inﬂuenza-associated
encephalopathy in infants [11,12] and multiple organ failure withvascular hyperpermeability, trypsins, trypsin-type proteases andMMP-
9 play major roles in the pathogenesis of severe IAV infection.
IAV infection causes marked increases in the levels of proinﬂamma-
tory cytokines by such as tumor necrosis factor (TNF)-α, interleukin (IL)
6, and IL-1β (i.e., cytokine storm), which affect host survival both
positively and negatively [13–15]. The inﬂammatory response also
affects cell adhesion, vascular permeability, apoptosis, and mitochon-
drial reactive oxygen species, potentially leading tovascular dysfunction
and multi-organ failure [16].
In this review, we discuss host cellular HA processing proteases for
seasonal and highly pathogenic avian inﬂuenza (HPAI) viruses and the
relationship among IAV, cytokines and host cellular proteases that
induce vascular hyperpermeability and multi-organ failure in severe
inﬂuenza. We also discuss the genetic background of inﬂuenza high
risk patients and effective targets for the control of IAV infection.
2. Host cellular viral envelope processing proteases of seasonal
human and highly pathogenic avian IAV
Limited proteolysis of envelope glycoprotein HA, is an important
step for IAV entry into cells. This cleavage induces thematuration of HA
protein and leads to the fusion between virions and host cell
membranes. However, IAV cannot process HA by itself, because no
HA-processing protease is encoded in its genome. Therefore, viral entry
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[3,17–19]. Proteolytic activation of seasonal human IAV HA occurs
extracellularly by airway proteases, such as tryptase Clara [18], mini-
plasmin [20], pancreatic trypsin [3], cellular trypsins [4,7,8,21], porcine
lung tryptase [22] and TC30 [23]. Fig. 1A shows that tryptase Clara
puriﬁed as a single protein band on SDS-PAGE under reducing
conditions from rat lung and cationic trypsin from bovine pancreas
cleave [3H]glucosamine-labeled inﬂuenza virus HA into subunits HA1
and HA2. Direct amino acid sequencing of the amino-terminus of the
HA2 subunit revealed residues G-L-F-G-A-I-A-G-, indicating that the
cleavage sites by tryptase Clara and trypsin was between R325 and G326,
the amino-terminal site of membrane fusion domain of HA [18]. Fig. 1B
shows that tryptase Clara and trypsin triggered the IAV infectivity in a
dose-dependent manner. Although the induction of infectivity by
tryptase Clara was less efﬁcient than that induced by trypsin, in
contrast, tryptase Clara cleaved selectively even at higher concentra-
tions and did not decrease viral infectivity.
In addition to these secreted-type serine proteases, transmembrane
serine protease 2 (TMPRSS2) and human airway trypsin-like protease
are also candidates for the processing proteases in the human airway
membrane [24]. In addition, it was reported recently that TMPRSS2 and
TMPRSS4proteolytically activate the1918Spanishﬂu inﬂuenzavirusHA
[25]. These trypsin-type endoproteases recognize the carboxylmoiety of
a single R residuewithin the consensus cleavagemotif Q/E-X-R (whereX
is any aminoacid except C andbasic amino acids) ofmost of the seasonal
human IAV known to date, including pneumotropic andneurotropic IAV
strains [26,27].
These proteases show different tissue distribution in the airway
[17]. Mini-plasmin, a truncated kringle 1–4 domains derivative of
plasmin, is found in folded rat epithelial cells; tryptase Clara is located
in Clara cells of rat inferior bronchiolar divisions, such as the terminal
and respiratory bronchioles; and lung anionic trypsin is distributed in
stromal cells of rat peri-bronchiolar regions. Under physiologic
conditions, the distribution of mini-plasmin is limited to rat superior
bronchiolar divisions but amounts as high as ~2 μMmay be producedFig. 1. Proteolytic activation of IAV Aichi/2/68(H3N2) in vitro by tryptase Clara and
trypsin. A. SDS-PAGE of the viral glycoproteins. [3H]Glucosamine-labeled non-activated
virus isolated from culture media of Madin–Darby canine kidney (MDCK) cells (lane 1)
was treated with bovine pancreatic cationic trypsin (10 μg/ml) for 15 min (lane 2),
tryptase Clara puriﬁed from rat lung (10 μg/ml) for 15 min (lane 3), tryptase Clara
(50 μg/ml) for 15 min (lane 4), or tryptase Clara (50 μg/ml) for 30 min (lane 5) at 37 °C.
SDS-PAGE proceeded on a 13% acrylamide gel under reducing conditions. B. Activation
of virus infectivity. Non-activated virus propagated inMDCK cells was suspended in PBS
(pH 7.2) and digested with trypsin (○) or with tryptase Clara (●) for 15 min at 37 °C.
The infectivity of the activated virus was assayed by immunoﬂuorescent cell-counting
method [18]. CIU, cell-infecting unit.from blood plasminogen at inﬂammatory loci by the processing
proteases, such as elastase and cathepsin G from granulocytes and
cathepsin D from monocytes, during clot formation in the lung
[17,20]. In addition, IAV infection induces marked upregulation of
cellular trypsins in the lung, heart, brain and vascular endothelial cells
[4,7,8]. These proteases may play critical roles in the spread of IAV
with vascular hyperpermeability and tissue damage. We also found
mast cell tryptase and tryptase TC30 as HA processing enzymes in
porcine lung, although human mast cell tryptase did not proteolyt-
ically activate HA0 of IAV in humans [22,23].
We found different potencies for these cellular proteases in the
proteolytic potentiation of various virus strains. As shown in Fig. 2,
among the proteases examined in our studies, pancreatic trypsin
efﬁciently activated the infectivity of almost all strains except IAV
WSN/33(H1N1), while small size derivatives of plasmin, such as mini-
plasmin andmicro-plasmin, a truncated kringle 1–5 domains derivative
of plasmin, also activated all strains though less efﬁciently than trypsin
[20]. The proteolytic potentiating activity of plasminwas the highest for
IAVWSN strain, weak for IAV Aichi/2/68(H3N2) strain, and nonexistent
for IAV seal/Massachusetts/1/81(H7N7). Mutational evolution of IAV
HA0 to adapt to these host cellular processing proteases in the airway
allows efﬁcientmultiplication of the virus in vivo and ultimately causing
epidemic of HA infection. In addition to the host cellular proteases,
microbial proteases also proteolytically activate inﬂuenza virus HA0 in
bacterial infection of the airways and play a role in the spread of the
virus [28,29].
As is the case for all HPAI viruses of subtypes H5 and H7 known to
date, the cleavage of HA occurs at the C-terminal R residue in the
consensus multi-basic motifs, such as R-X-K/R-R with R at position P4
and K-K/R-K/T-R with K at P4, and leads to systemic infection. The
trypsin type serine proteases for seasonal human IAV described above
are not susceptible for proteolytic cleavage of HA of HPAI virus. Early
studies demonstrated that the ubiquitously expressed furin and
proprotein convertases (PCs) are activating proteases of HPAI viruses
[30–34]. Furin and PCs are calcium-dependent subtilisin-like serine
proteases in the trans-Golgi network that cleave the consensus multi-
basic motif R-X-K/R/X-R with R at position P4 [35–39]. However,
replacement of P4 R by K and a nonbasic amino acid signiﬁcantly
suppresses the processing activities of furin and PCs [37,39,40]. These
ﬁndings suggest the possible involvement of host cellular protease(s),
other than furin and PCs, in the processing of HA of HPAI viruses with
multi-basic cleavage motifs with K at position P4.
We recently found that ubiquitous type II transmembrane serine
proteases (TTSPs), MSPL and its splice variant TMPRSS13, are novel
candidates of HA processing proteases of all HPAI viruses known to date
[41–44]. The TTSPs have a common structure; a short cytoplasmic
domain and a transmembrane domain at the N-terminus side, and a
serine protease domain at the extracellular C-terminus. Most of the
TTSPs identiﬁed so far recognize a single R at position P1, but the newly
isolated MSPL/TMPRSS13 has unique substrate speciﬁcities of the
preferential recognition of a paired basic residue at the cleavage site
[41,43,44]. Thus, MSPL/TMPRSS13, which are ubiquitously expressed in
theplasmamembranes, particularly highly expressed in the lungs, brain
and vascular epithelial cells of human and chicken [42,43], can activate
various fusogenic viral envelope glycoproteins of HPAI viral strains. To
clarify the roles of MSPL and TMPRSS13 in the proteolytic activation of
HA of HPAI viruses, we searched for cells that express MSPL/TMPRSS13
at belowdetection levels and found human endothelial cell line ECV304
as the corresponding cell line. We then established MSPL/TMPRSS13
stably expressing ECV304 cells.
Fig. 3 shows the role of MSPL/TMPRSS13 in HAPI virus infection and
multiplication. Wild type (WT) ECV304 cells, ECV304-WT, and stable
transfectant ECV304 cells expressing full-length humanMSPL, ECV304-
MSPL, were infected with the HPAI virus A/Crow/Kyoto/53/2004
(H5N1) (HA:N′-R-K-K-R↓G-C′) [41] and the geneticallymodiﬁedmutant
recombinant virus (HA: N′-K-K-K-R↓G-C′). Although processing of HA
Fig. 2. Potentiation by plasmin, mini-plasmin, microplasmin, and trypsin of IAV WSN(H1N1) (A), IAV seal/Massachusetts/1/81(H7N7) (B), and IAV Aichi/2/68(H3N2) (C). MDCK
cell-grown non-activated IAV strains were treated for 30 min at 37 °C with trypsin (●), plasmin (○), mini-plasmin (▲), or microplasmin (■) at the indicated concentrations. The
enzyme reaction was stopped by the addition of 100 μM aprotinin. Infectivity is shown as cell-infecting unit (CIU).
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in ECV-WT cells was hardly detected, conversion of HA0 to the mature
form was detected in ECV-MSPL cells. In addition, this conversion
was suppressed by Bowman–Birk trypsin inhibitor (BBI), a membrane
non-permeable high-molecular mass inhibitor against MSPL/TMPRSS13.
To test for the generation of infective virus, the conditioned media from
1-day cultures of ECV304-WT and ECV304-MSPL cells infected with WT
and mutant HPAI H5N1 viruses were inoculated into newly prepared
cells and cultured for 24 h. Although infectionwithWTvirus carrying the
HA cleavagemotif of R-K-K-R spread from the conditionedmedia of both
ECV304-WT and ECV304-MSPL cells, infection with mutant virus
carrying the HA cleavage motif K-K-K-R spread only from the condition
medium of ECV304-MSPL cells. These results strongly suggest that the
expression of MSPL, but not furin, potentiates multicycle replication of
HPAI virus with the K-K-K-R HA cleavage motif. The cleavability of HA
peptides of 14-residues synthetic peptides derived from HA cleavage
sites of HPAI strains, such as A/chick/Penn/1370/83 (H5N2) [45] and A/
FPV/Rostock/34 (H7N1) [31], byMSPL/TMPRSS13wasalso studied.MSPL
cleaved both the H5 HA peptide with the K-K-K-R motif and the H7 HA
peptide with the R-K-K-R motif at the correct positions, while furin
cleaved only at a single site of R with R at position P4, N′-K-K-R-K-K-R↓-
G-C′ and hardly cleaved the H5 HA peptide with K at position P4. These
ﬁndings suggest that MSPL/TMPRSS13 covers diverse cleavage speciﬁc-
ities including non-susceptible speciﬁcity to furin.
3. Inﬂuenza virus–cytokine–protease cycle in the pathogenesis of
vascular hyperpermeability and multiple organ failure in
severe inﬂuenza
IAV infection increases the levels of proinﬂammatory cytokines
such as TNF-α, IL-6, and IL-1β in the airway and blood. These
cytokines upregulate cellular trypsins and MMP-9 through activation
of nuclear factor-kappa B (NF-κB) and activator protein 1 (AP-1) [7].
Fig. 4 is a schematic illustration of a typical series of biological
responses in the airway ﬂuid of mice after IAV infection. The initialresponse before the peak of viral proliferation at days 4–5 post-
infection is signiﬁcant increases in proinﬂammatory cytokine levels
(“cytokine storm”). Immediately after that, ectopic trypsin and MMP-
9 are markedly upregulated, and viral titers increase in the airway.
Just after the peak of viral proliferation, the innate and adaptive
immune responses of protective immunity are induced for defense
and recovery, or oppositely on rare occasions, multi-organ failure.
Fig. 5 shows upregulation of cytokines and cellular trypsins,
increase in viral RNA after IAV infection, and effects of NF-κB and AP-1
inhibitors on the upregulation and survival of infectedmice. The levels
of TNF-α and IL-6 in the lungs, the site of initial virus infection, were
increased persistently for 6 days, and that of IL-1β peaked at days 4–6
post-infection (Fig. 5A). Since these cytokine responses are associated
with activation of transcription factors, NF-κB and AP-1 [15,46–48],
we treated mice once daily for 4 days with NF-κB inhibitors:
pyrrolidine dithiocarbamate (PDTC) and N-acetyl-L-cysteine (NAC),
and AP-1 inhibitors: nordihydroguaiaretic acid (NDGA). PDTC and
NDGA signiﬁcantly suppressed the upregulation of TNF-α and IL-1β
(Pb0.001), and NAC suppressed TNF-α (Pb0.001) and IL-6 (Pb0.01)
at day 4 post-infection. Trypsin activities analyzed by gelatin
zymography showed upregulation of cellular trypsins in mice lung,
brain, and heart during infection for 6 days (Fig. 5B). Trypsin
induction was inhibited also by treatment with PDTC, NAC and
NDGA, probably via blockade of NF-κB and AP-1 binding in the
promoter region of the gene (S.R. Talukder et al., manuscript in
preparation). Viral RNA replication in various organs at day 4 post-
infection was suppressed by more than one order of magnitude by
PDTC, NAC and NDGA (Fig. 5C). Suppression of viral multiplication
and induction of cytokines and trypsins by treatment with these
inhibitors signiﬁcantly improved the survival of mice at day 14 post-
infection (Fig. 5D).
In most animal species, trypsin has three major isoforms: cationic
trypsin (T1), anionic trypsin (T2), and mesotrypsin (T3) [49,50]. To
analyze the linkage between these cytokines and cellular trypsins in
human endothelial cells, changes in the expression of human trypsin
Fig. 3. Cleavage of HA proteins inWT HPAI virus A/Crow/Kyoto/53/2004 (H5N1) and themutant (Mut) virus byMSPL andmultiple infections with the viruses. (A) ECV304-MSPL and
ECV304-WT cells were infected withWT HPAI virus A/Crow/Kyoto/53/2004 (H5N1) (H5N1-WT; carrying the HAmotif R-K-K-R) and genetically modiﬁedmutant virus (H5N1-Mut;
carrying the HA motif K-K-K-R) for 24 h. The cell lysates were subjected to SDS-PAGE and analyzed by western immunoblotting with anti-H5N1 monoclonal antibody (4 C12).
Bowman–Birk trypsin inhibitor (BBI), an inhibitor of MSPL [41]. Molecular massmarkers are on the right. (B) Immunoﬂuorescence assay was performed as described previously [41].
The cells were ﬁxed with 4% paraformaldehyde in PBS containing 0.1% Triton-X-100. The binding of polyclonal antibodies to the viral protein was detected with an AlexaFluor 488-
conjugated secondary antibody (1:500). Bar, 50 μm.
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TNF-α, IL-6, and IL-1β (Fig. 6). All tested cytokines tended to
upregulate hPRSS expression levels, especially TNF-α (##Pb0.01)
and IL-1β (#Pb0.05), and the upregulation was inhibited by
simultaneous treatment with the respective neutralizing antibodies
(100 ng/ml) to these cytokines (*Pb0.05; **Pb0.01). Cellular trypsins
mediate the post-translational proteolytic cleavage of viral envelope
HA and subsequent tissue damage in various organs. These resultsFig. 4. Schematic diagram of host cellular responses in the mouse airway after IAV
infection.suggest close relationship among factors, inﬂuenza virus, cytokines
and host cellular proteases cycle in the pathogenesis of inﬂuenza.
Fig. 7 shows the results of studies on upregulation of trypsin and
MMP-9 in the myocardium associated with increased vascular
hyperpermeability, tissue edema, and inﬂammatory cell inﬁltration
after IAV infection in mice [8]. In these studies, mice intra-nasally
inoculated with IAV exhibited acute myocarditis, as conﬁrmed by
histological examination of hematoxylin and eosin-stained sections.
Inﬂammatory inﬁltrates appeared in the subepicardium at day 3 post-
infection, followed by extensive inﬁltration across the interstitium
and perivascular areas deep into the myocardium, accompanied by
extracellular matrix destruction during days 6 and 9, and then
alleviated at day 12 (Fig. 7A–C).Coronary vascular permeability,
monitored by extravasation (using Evans blue dye) and tissue edema
(bywet/dry ratio), started to increase at day 3 after infection, reaching
a peak during days 6 and 9, and then decreased signiﬁcantly at day 12.
Trypsin in mice has also three major isoforms (T1–3) [50]. In the
above studies, infection of IAV ﬁrst upregulated trypsins (T1–3) in the
heart at day 3, reached a peak at day 6, remained at high levels until day
9, and then started to decrease at day 12 (Fig. 7D) [8]. The majorities of
upregulated T1–3 were trypsinogens, as determined by western
immunoblotting, and were partially converted to active trypsins with
a peak at day 6 monitored by zymography. In uninfected mice, T2 was
the predominant isoform in the heart, while the level of T1was less than
that of T2, and T3 was barely detected. After infection, T2 was
predominantly induced with a peak during days 6 and 9 (Fig. 7E). The
viral levels in the heart monitored by viral NS1 gene and nucleoprotein
(NP) showed that it also peaked at day 6 and started to decrease at day 9
(Fig. 7F). Analysis of the distribution of the increased levels of trypsins,
Fig. 5. Upregulation of cytokines and trypsins, increase in viral RNA after IAV infection in mice, and effects of NF-κB and AP-1 inhibitors on the upregulation and survival of infected mice.
(A) Mice were infected with 250 plaque-forming units (PFU) of IAVWSN/33(H1N1) virus (WSN) with and without treatment with pyrrolidine dithiocarbamate (PDTC), N-acetyl-L-cysteine
(NAC), and nordihydroguaiaretic acid (NDGA). Levels of tumor necrosis factor (TNF)-α, interleukin (IL)-6, and IL-1β in lung homogenates (n=3)were analyzed before (Control) and at day 2
(WSN-D2), day 4 (WSN-D4) andday 6 (WSN-D6) after infection. Cytokine levels in lungs of animals treated once daily for 4 dayswith PDTC (PDTC-D4), NAC (NAC-D4), andNDGA (NDGA-D4)
were alsomeasured.Data aremean±SEM. **Pb0.01, #Pb0.001, versusWSN-D4. (B) Trypsin activities analyzedbygelatin zymographyof infectedmice for 0–6 days. Animalswere treatedwith
PDTC, NAC, and NDGA once daily for 4 days. Each lane represents the same experimental conditions as in (A). (C) Mice were infected withWSN and also treated with PDTC, NAC, and NDGA.
Quantitative analysis of viral NS1 RNA copies normalized by β-actin at day 4 after infection was conducted by real-time PCR (n=3). Data are mean±SEM. #Pb0.001 versus without drug
treatment. (D)Survival rates.Miceof eachgroup(n=10)were infectedwithWSNat250PFUand500PFU.Animals infectedwithWSNat250PFUwere treatedwithPDTC,NAC, andNDGAonce
daily for 4 days, and the survival rates of the different groups were compared. *Pb0.05, #Pb0.001 versus without drug treatment.
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tissue injury) showed their overlapped localization, suggesting their
close relationship in the infected foci [8].Fig. 6. Increase in human trypsin (hPRSS) expression in endothelial cells after WSN infecti
mRNA levels in the cells measured by RT-PCR after viral infection for 0–12 h and the perc
treatment with cytokine (TNF-α, IL-6, and IL-1β) for 6 h and their suppression by anti-cyt
**Pb0.01, *Pb0.05, versus treatment with each antibody.Limited amounts of trypsin(s) effectively converts various proMMPs,
particularly proMMP-9, into active MMPs [51,52] and the latter in turn
convert proinﬂammatory cytokines to active cytokines [53], resulting inon and cytokine treatment, and its suppression by anti-cytokine antibodies. (A) hPRSS
entage change in the expression. (B) Increase in hPRSS mRNA levels in the cells after
okine antibodies. Data are mean±SEM (n=3). ##Pb0.01, #Pb0.05 versus the control.
Fig. 7. Increased vascular hyperpermeability, tissue edema and inﬂammatory cell inﬁltration in acute myocarditis, and kinetics of upregulation of trypsins in the myocardium after
IAV infection. (A) Vascular hyperpermeability monitored by extravasation (Evans blue staining) during the course of infection from day 0 (d 0) to 12 (d 12). (B) Hematoxylin and
eosin staining. Bar=50 μm. (C) Heart edema determined by wet/dry weight ratio. Data are mean±SD of 10 mice in each group. ⁎⁎Pb0.01 versus d 0; ††Pb0.01 versus d 9. (D1, E and
F1) RT-PCR-based detection of trypsin1–3, trypsin isoforms T1, T2 and T3 and IAV NS1 gene in the hearts from day 0 to 12 after infection. (D2) Detection of trypsin activity by
zymography, (D3) trypsinogen and trypsin by western immunoblotting, and (F2) viral nucleoprotein (NP). (G) Kinetics of up-regulation of proMMP-9, proMMP-2, and activated
(act) MMP-9 in the hearts determined by zymography (G1) and western immunoblotting (G2) from day 0 to 12 post-infection. Each result is representative of three experiments.
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an increase in trypsin levels, upregulated proMMP-9 was readily
converted to active MMP-9 (actMMP-9) from day 3 postinfection,
whereasupregulatedproMMP-2wasnot (Fig. 7G). The actMMP-9 levels
increased to a peak value during day 6 and 9, followed by a decrease in
the levels at day 12.
4. Trypsin knockdown inhibits inﬂuenza virus–cytokine–protease
cycle and mitochondrial ATP depletion
Sincehost cellular trypsins facilitate IAV entry and viral replication in
target cells and trypsin efﬁciently converts proMMPs to active MMPs in
tissues, we analyzed the effects of silencing major trypsin genes, T1 and
T2 in mice heart, on viral replication and production of actMMP-9 and
cytokines in cardiomyoblast H9c2 cells. The expression levels of T1 and
T2 genes determined by RT-PCR were selectively and signiﬁcantly
suppressed in trypsin1-short hairpin (sh) RNA gene silencing plasmid
(T1-sh) and trypsin2-shRNA gene silencing plasmid (T2-sh) cells,
respectively, compared with their levels in the control (C-sh) cells
(Fig. 8A) [8]. Viral replication monitored by NS1 gene and the levels of
viral NP showed signiﬁcant suppression of IAV replication in T1- and T2-
knockdown cells; the magnitude of suppression in T2-knockdown was
signiﬁcantly higher than in T1-knockdown (Fig. 8B1–2). Furthermore, a
signiﬁcant reduction in the number of immunoﬂuorescence-labeled
viral antigen in the infected cells (red) was detected under T1- and T2-
knockdown conditions, particularly T2-knockdown condition, com-
pared to those in C-sh cells (Fig. 8C1–2).
Upregulation of both proMMP-9 and proMMP-2 was detected in
C-sh cells after infection and the upregulation was signiﬁcantly
suppressed by T1- and T2-knockdown; the magnitude of suppressionwas higher in T2-knockdown than in T1-knockdown (Fig. 8D).
Furthermore, a signiﬁcant suppression of actMMP-9 production
monitored by the ratio of actMMP-9/proMMP-9 was observed in
culture media of T1- and T2-knockdown cells, the efﬁciency of T2-
knockdown was higher than in T1-knockdown.
Induction of proinﬂammatory cytokines (IL-6, IL-1β and TNF-α) by
IAV infection in culture media, was suppressed under T1- and T2-
knockdown conditions, particularly IL-6 in T2-knockdown (Fig. 9A)
[8]. Since inﬂuenza-associated encephalopathy is a sign of impaired
mitochondrial fuel utilization in severe inﬂuenza with multiple organ
failure [54], we further analyzed the effects of trypsin knockdown on
mitochondrial membrane potential (ΔΨm), intracellular ATP level and
apoptosis after IAV infection for 24 h. Active mitochondria with high
ΔΨm appeared red by cationic lipophilic probe JC-1[54,55], as shown
in the cells with mock infection (Fig. 9B, C-sh, mock). Viral infection
markedly reduced the red ﬂuorescence indicating mitochondrial
depolarization, and reduction of ΔΨm. T1- and T2-knockdown,
particularly T2-knockdown, improved the infection-induced mito-
chondrial depolarization (Fig. 9B, T2-sh, infection) [8]. The numbers of
apoptotic cells analyzed by TUNEL staining were signiﬁcantly reduced
under T1- and T2-knockdown conditions, particularly T2-knockdown
condition. Furthermore, ATP levels were reduced in H9c2 cells to
about 61% after viral infection and this reduction was abrogated by
trypsin-knockdown, particularly T2-knockdown (Fig. 9C).
IAV infection induces impaired fuel utilization as described above.
A large proportion of patients suffering from disabling or fatal
inﬂuenza-associated encephalopathy exhibits a thermolabile pheno-
type of compound homo/heterozygous variants of carnitine palmi-
toyltransferase II (CPT II) [54,56,57]. CPT Ι and II are important factors
in ATP generation through mitochondrial long-chain fatty acid
Fig. 8. Effects of trypsin knockdown on IAV replication, MMPs upregulation and actMMP-9 production in H9c2 cardiomyoblasts. (A) Silence efﬁciency of T1 and T2 genes was
determined by RT-PCR in T1-sh, T2-sh and C-sh cell lines. (B1) Effects of T1- and T2-knockdown on viral replication monitored by NS1 gene in cell lysates by RT-PCR, NP in culture
media by western immunoblotting, and (B2) relative values of NS1 and NP versus infection control (C-sh). (C1) Detection of viral antigen by immunoﬂuorescence (red) in H9c2 cells
at 24 h after infection. Nuclei were stained by 4,6-diamidino-2-phenylindole (DAPI). Bar=25 μm. (C2) Percentage of infected cells. Data are mean±SD of three independent
experiments. (D) Effects of T1- and T2-knockdown on the expression of proMMP-9, proMMP-2 and actMMP-9 in cell lysates and culture media of T1-sh, T2-sh, and C-sh cells infected
with IAV or mock monitored by western immunoblotting. ⁎Pb0.05, ⁎⁎Pb0.01 versus mock infection; ††Pb0.01 versus infection control; ##Pb0.01 versus T1-knockdown.
192 H. Kido et al. / Biochimica et Biophysica Acta 1824 (2012) 186–194oxidation [58–60]. ATP generation in endothelial cells, in particular, is
derived as much as 70% from fatty acid oxidation versus 30%
from glycolysis [61]. Considered together, these results suggest the
involvement of inﬂuenza virus–cytokine–protease cycle in endothelial
cells of patients with disordered mitochondrial fatty acid oxidation, in
the enhanced development of severe vascular dysfunction, resulting in
multiple organ failure.
5. Conclusions
It has been known for decades that the infectivity, infectious organ
tropism and pathogenicity of IAV are primarily determined by host
cellular trypsin-type proteases, which cleave the viral envelope fusion
glycoprotein precursor HA0, because a HA-processing protease is not
encoded in the viral genome. Although there are many host cellular
proteases that recognize the carboxyl moiety of R residue as
determined by synthetic substrates, only few proteases recognize
the tertiary structure of the cleavage site of HA0, thus allowing IAV
multiplication with proteolytic activation only in organs that express
the HA-processing proteases [5,17,18]. As outlined in this review, the
knowledge gained within the last few years has greatly improved our
understanding on the role of host cellular proteases in thepathogenicity of IAV infection: (i) Several cell surface anchored
trypsin-like serine proteases are candidates of HA-processing prote-
ase for seasonal human IAV, TMPRSS2, HAT and TMPRSS4. This is in
addition to secreted HA-processing trypsin-type proteases in the
airway, such as tryptase Clara, trypsin and mini-plasmin. In addition,
MSPL and TMPRSS13, plasma membrane bound HA-processing
proteases for HPAI viruses other than furin and PCs are found. Furin
preferentially cleaves only HA with the R-K-K-R cleavage site motif
with R at position P4, whereas MSPL/TMPRSS13 cleaves HA, including
a wide range of strains of HPAI virus with the R/K-K-K-R motif with
both K and R at position P4. (ii) IAV infection upregulates cellular
trypsins, MMPs and cytokines, and also ATP depletion in various
infected cells. The upregulated trypsins in various organs including
endothelial cells changes IAV infectious organ tropism of seasonal IAV.
Destruction of endothelial cell tight junctions by the induced trypsins
causes viral invasion in various organs. Based on the results of studies
on the relationship among upregulated factors, we propose the
inﬂuenza virus–cytokine–protease cycle hypothesis as one of the
main mechanisms of vascular dysfunction in multiorgan failure, in
association with cytokine storm in severe inﬂuenza (Fig. 10) [7].
(iii) Inhibitors of NF-κB and AP-1 effectively suppress the upregula-
tion of proinﬂammatory cytokines and cellular trypsins, and improve
Fig. 9. IAV infection-induced cytokine upregulation, mitochondrial membrane depolarization, ATP depletion and apoptosis, and abrogation by T1- and T2-knockdown in H9c2
cardiomyoblasts. (A) Effects of T1- and T2-knockdown on IL-6, IL-1β, and TNF-α levels in culture mediawere analyzed by ELISA at 24 h after infection. (B)ΔΨm of C-sh, T1-sh and T2-sh cells
infected with mock or IAVwas analyzed after IAV infection for 24 h. Top: ΔΨmwas monitored by treatment for 15 min with JC-1 (red). Bottom: Apoptotic cells detected by TUNEL staining
(lightblue).Nucleiwere stainedbyDAPI. Bar=25 μm.Right: Percentageof apoptotic cells among total cells. (C)ATP levelsunder thesameexperimental conditions inB.Data aremean±SDof
three independent experiments. ⁎Pb0.05, ⁎⁎Pb0.01 versus mock infection; †Pb0.05, ††Pb0.01 versus infection control; #Pb0.05, ##Pb0.01 versus T1-knockdown.
193H. Kido et al. / Biochimica et Biophysica Acta 1824 (2012) 186–194survival rates of infected mice. In addition, administration of trypsin-
type protease inhibitor aprotinin suppresses viral replication [7],
upregulation of trypsins, MMPs and cytokines as well as ATP depletion
and signiﬁcantly improves cardiac function [8]. More selectively,
trypsin-knockdown, particularly T2-knockdown, in cardiomyoblasts
effectively suppresses IAV replication and ATP depletion accompanied
by protection against mitochondrial membrane depolarization and
apoptosis. These results suggest that upregulated cellular trypsins areFig. 10. The hypothesis of “Inﬂuenza–cytokine–protease cycle”, involved in the
pathogenesis of vascular hyperpermeability and tissue destruction in severe inﬂuenza.
BBB, blood–brain barrier.one of the key pathogenic host factors in IAV-induced multiple organ
failure. (iv) Since IAV infection induces impaired fuel utilization,
patients with disorders of mitochondrial fatty acid oxidation are
prone to severe multiple organ failure after IAV infection. (v)
Upregulated cellular trypsins in various organs and endothelial cells
might be effective drug targets for the control of multiple organ failure
in severe inﬂuenza.Acknowledgment
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